CLINICAL_TRIALS
trial_result
· 2021-12-22
Clinical Trial Update: Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension [Phase 2]
Summary
Phase 2 clinical trial update reporting long-term safety and efficacy of ralinepag in pulmonary arterial hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-12-22